Literature DB >> 9530088

Characterization of a transient outward K+ current with inward rectification in canine ventricular myocytes.

G R Li1, H Sun, S Nattel.   

Abstract

The threshold potential for the classical depolarization-activated transient outward K+ current and Cl- current is positive to -30 mV. With the whole cell patch technique, a transient outward current was elicited in the presence of 5 mM 4-aminopyridine (4-AP) and 5 microM ryanodine at voltages positive to the K+ equilibrium potential in canine ventricular myocytes. The current was abolished by 200 microM Ba2+ or omission of external K+ (K+o) and showed biexponential inactivation. The current-voltage relation for the peak of the transient outward component showed moderate inward rectification. The transient outward current demonstrated voltage-dependent inactivation (half-inactivation voltage: -43.5 +/- 3.2 mV) and rapid, monoexponential recovery from inactivation (time constant: 13.2 +/- 2.5 ms). The reversal potential responded to the changes in K+o concentration. Action potential clamp revealed two phases of Ba2(+)-sensitive current during the action potential, including a large early transient component after the upstroke and a later outward component during phase 3 repolarization. The present study demonstrates that depolarization may elicit a Ba2(+)- and K(+o)-sensitive, 4-AP-insensitive, transient outward current with inward rectification in canine ventricular myocytes. The properties of this K+ current suggest that it may carry a significant early outward current upon depolarization that may play a role in determining membrane excitability and action potential morphology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9530088     DOI: 10.1152/ajpcell.1998.274.3.C577

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  A-type K+ channels encoded by Kv4.2, Kv4.3 and Kv1.4 differentially regulate intrinsic excitability of cortical pyramidal neurons.

Authors:  Yarimar Carrasquillo; Andreas Burkhalter; Jeanne M Nerbonne
Journal:  J Physiol       Date:  2012-05-21       Impact factor: 5.182

2.  Associative pairing enhances action potential back-propagation in radial oblique branches of CA1 pyramidal neurons.

Authors:  Sonia Gasparini; Attila Losonczy; Xixi Chen; Daniel Johnston; Jeffrey C Magee
Journal:  J Physiol       Date:  2007-02-01       Impact factor: 5.182

3.  Roles of specific Kv channel types in repolarization of the action potential in genetically identified subclasses of pyramidal neurons in mouse neocortex.

Authors:  Dhruba Pathak; Dongxu Guan; Robert C Foehring
Journal:  J Neurophysiol       Date:  2016-02-10       Impact factor: 2.714

4.  Evolution of activation patterns during long-duration ventricular fibrillation in pigs.

Authors:  Kang-An Cheng; Derek J Dosdall; Li Li; Jack M Rogers; Raymond E Ideker; Jian Huang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-16       Impact factor: 4.733

5.  Human Kir2.1 channel carries a transient outward potassium current with inward rectification.

Authors:  De-Yong Zhang; Chu-Pak Lau; Gui-Rong Li
Journal:  Pflugers Arch       Date:  2008-11-11       Impact factor: 3.657

6.  Characterization of multiple ion channels in cultured human cardiac fibroblasts.

Authors:  Gui-Rong Li; Hai-Ying Sun; Jing-Bo Chen; Yuan Zhou; Hung-Fat Tse; Chu-Pak Lau
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

7.  A new model of myofibroblast-cardiomyocyte interactions and their differences across species.

Authors:  Fusheng Liu; Hou Wu; Xiaoyu Yang; Yuqin Dong; Guoyou Huang; Guy M Genin; Tian Jian Lu; Feng Xu
Journal:  Biophys J       Date:  2021-07-17       Impact factor: 3.699

8.  Investigation of the Effects of the Short QT Syndrome D172N Kir2.1 Mutation on Ventricular Action Potential Profile Using Dynamic Clamp.

Authors:  Chunyun Du; Randall L Rasmusson; Glenna C Bett; Brandon Franks; Henggui Zhang; Jules C Hancox
Journal:  Front Pharmacol       Date:  2022-01-18       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.